Teva Pharmaceutical Industries Ltd.

TEVA·NYSE·$34.61Share Price as of 11/2·$40BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2607/29/26 10-QQ1 ended 03/31/2604/29/26 10-KFY 202502/03/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2507/30/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report09/16/26 8-KCurrent report09/14/26 8-KCurrent report09/11/26 8-KCurrent report09/03/26

Prospectuses and Registrations

FWPFree writing prospectus09/10/26 FWPFree writing prospectus09/10/26 424B5Prospectus supplement09/08/26 F-6 POSProspectus / registration07/29/26 424B5Prospectus supplement05/22/25

Proxies

DEF 14ADefinitive proxy03/31/26 DEFA14AAdditional proxy materials03/31/26 DEF 14ADefinitive proxy04/09/25 DEFA14AAdditional proxy materials04/09/25 DEF 14ADefinitive proxy04/16/24

Ownership

Form 3Initial insider ownership10/08/26 Form 4Insider transaction09/22/26 Form 4Insider transaction09/22/26 144Proposed sale of securities09/21/26 144Proposed sale of securities09/18/26

Other

25-NSERemoval from listing09/14/26 8-A12B/A8-A12B/A09/14/26 ARSAnnual report to shareholders03/31/26 SDConflict Minerals disclosure06/02/25 UPLOADLetter from the SEC04/28/25